Trial Profile
Use of an Aluvia Based Highly Active Antiretroviral Therapy (HAART) Regimen in the Prevention of Mother to Child HIV Transmission (PMTCT) Antepartum, Intrapartum and Postpartum in Africa.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Lamivudine/zidovudine; Nevirapine
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PMTCT
- 23 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Mar 2010 New trial record